Quick Answer
UNITED THERAPEUTICS Corp reported Shares Outstanding of 43.64 million shares for fiscal year 2025.
UNITED THERAPEUTICS Corp Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 43.64M | -2.7% |
| 2024 | 44.83M | -4.7% |
| 2023 | 47.04M | +2.2% |
| 2022 | 46.03M | +2.0% |
| 2021 | 45.11M | +1.3% |
| 2020 | 44.51M | +1.4% |
| 2019 | 43.88M | +0.7% |
| 2018 | 43.59M | +0.8% |
| 2017 | 43.24M | +0.6% |
| 2016 | 42.97M | -6.1% |
| 2015 | 45.76M | -2.9% |
| 2014 | 47.11M | -6.5% |
| 2013 | 50.39M | +0.4% |
| 2012 | 50.17M | -6.4% |
| 2011 | 53.61M | -6.9% |
| 2010 | 57.56M | +6.2% |
| 2009 | 54.22M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 42.90M | -3.8% | -5.1% |
| June 30, 2025 | 45.22M | +1.8% | +0.3% |
| March 31, 2025 | 45.07M | +2.0% | +0.5% |
| December 31, 2024 | 44.83M | -4.7% | +0.5% |
| September 30, 2024 | 44.62M | -5.0% | +0.4% |
| June 30, 2024 | 44.42M | -5.3% | +0.5% |
| March 31, 2024 | 44.20M | -5.3% | -6.0% |
| December 31, 2023 | 47.04M | +2.2% | +0.1% |
- UNITED THERAPEUTICS Corp showed a decrease of -2.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2009–2025 period, UNITED THERAPEUTICS Corp’s shares outstanding has declined by 19.5% (from 54.22 million shares to 43.64 million shares).
- The most recent figure is from UNITED THERAPEUTICS Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: